Login / Signup

New mammography screening performance metrics based on the entire screening episode.

Brian L SpragueDiana L MigliorettiChristoph I LeeHannah PerryAnna A N TostesonKarla Kerlikowske
Published in: Cancer (2020)
Established screening performance metrics underestimate the interval cancer rate of a mammography screening episode, particularly for women with dense breasts or an elevated breast cancer risk. Women, clinicians, policymakers, and researchers should use final-assessment performance metrics to support informed screening decisions.
Keyphrases
  • breast cancer risk
  • squamous cell carcinoma
  • type diabetes
  • magnetic resonance imaging
  • contrast enhanced
  • magnetic resonance
  • adipose tissue
  • metabolic syndrome
  • pregnant women
  • skeletal muscle
  • papillary thyroid